CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

January 13, 2016 · Phase 3 readout

BMRN Phase 3 readout: a negative outcome, -9.7%

On January 13, 2016, BioMarin Pharmaceutical Inc. reached its Phase 3 readout. The result was a negative outcome, and the stock moved -9.7% in the window around the event.

The move

$93.11
1d before
$84.12
Event day
$84.43
1d after
$83.14
5d after

Pre-catalyst setup

+1.6%
30-day run-up
3310%
30-day volatility
1.4×
volume spike